OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emergence and phenotypic characterization of the global SARS-CoV-2 C.1.2 lineage
Cathrine Scheepers, Josie Everatt, Daniel G. Amoako, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution
Tyler N. Starr, Allison J. Greaney, William W. Hannon, et al.
Science (2022) Vol. 377, Iss. 6604, pp. 420-424
Open Access | Times Cited: 248

The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance
Houriiyah Tegally, James Emmanuel San, Matthew Cotten, et al.
Science (2022) Vol. 378, Iss. 6615
Open Access | Times Cited: 118

COVID-19 Diagnosis: A Comprehensive Review of the RT-qPCR Method for Detection of SARS-CoV-2
Debashis Dutta, Sarah Naiyer, Sabanaz Mansuri, et al.
Diagnostics (2022) Vol. 12, Iss. 6, pp. 1503-1503
Open Access | Times Cited: 69

Neutralizing antibody activity against 21 SARS-CoV-2 variants in older adults vaccinated with BNT162b2
Joseph Newman, Nazia Thakur, Thomas P. Peacock, et al.
Nature Microbiology (2022) Vol. 7, Iss. 8, pp. 1180-1188
Open Access | Times Cited: 66

Identification of SARS‐CoV‐2 Omicron variant using spike gene target failure and genotyping assays, Gauteng, South Africa, 2021
Kathleen Subramoney, Nkhensani Mtileni, Avani Bharuthram, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 8, pp. 3676-3684
Open Access | Times Cited: 32

Electrostatic Features for the Receptor Binding Domain of SARS-COV-2 Wildtype and Its Variants. Compass to the Severity of the Future Variants with the Charge-Rule
Fernando Luís Barroso da Silva, Carolina Corrêa Giron, Aatto Laaksonen
The Journal of Physical Chemistry B (2022) Vol. 126, Iss. 36, pp. 6835-6852
Open Access | Times Cited: 32

SARS-CoV-2 Spike N-Terminal Domain Engages 9-O-Acetylated α2–8-Linked Sialic Acids
Ilhan Tomris, Luca Unione, Linh Nguyen, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 5, pp. 1180-1191
Open Access | Times Cited: 19

The Impact of SARS-CoV-2 Lineages (Variants) and COVID-19 Vaccination on the COVID-19 Epidemic in South Africa: Regression Study
Thabo Mabuka, Natalie Naidoo, Nesisa Ncube, et al.
JMIRx Med (2023) Vol. 4, pp. e34598-e34598
Open Access | Times Cited: 11

Molecular Epidemiology of SARS-CoV-2 during Five COVID-19 Waves and the Significance of Low-Frequency Lineages
Kathleen Subramoney, Nkhensani Mtileni, Jennifer Giandhari, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1194-1194
Open Access | Times Cited: 11

Population shift in antibody immunity following the emergence of a SARS-CoV-2 variant of concern
Jinal N. Bhiman, Vimbai Sharon Madzorera, Qiniso Mkhize, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Prediction of Omicron Virus Using Combined Extended Convolutional and Recurrent Neural Networks Technique on CT-Scan Images
Anand Kumar Gupta, Asadi Srinivasulu, Kamal Kant Hiran, et al.
Interdisciplinary Perspectives on Infectious Diseases (2022) Vol. 2022, pp. 1-11
Open Access | Times Cited: 12

Alum/CpG Adjuvanted Inactivated COVID-19 Vaccine with Protective Efficacy against SARS-CoV-2 and Variants
Yuntao Zhang, Xiaotong Zheng, Wang Sheng, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1208-1208
Open Access | Times Cited: 11

mRNA-based COVID-19 booster vaccination is highly effective and cost-effective in Australia
Rui Li, Hanting Liu, Christopher K. Fairley, et al.
Vaccine (2023) Vol. 41, Iss. 15, pp. 2439-2446
Open Access | Times Cited: 6

Convergence of immune escape strategies highlights plasticity of SARS-CoV-2 spike
Xiaodi Yu, Jarek Juraszek, Lucy Rutten, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 5, pp. e1011308-e1011308
Open Access | Times Cited: 6

Differences between Omicron SARS-CoV-2 RBD and other variants in their ability to interact with cell receptors and monoclonal antibodies
Carolina Corrêa Giron, Aatto Laaksonen, Fernando Luís Barroso da Silva
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 12, pp. 5707-5727
Open Access | Times Cited: 9

Leveraging South African HIV research to define SARS‐CoV‐2 immunity triggered by sequential variants of concern
Jinal N. Bhiman, Penny L. Moore
Immunological Reviews (2022) Vol. 310, Iss. 1, pp. 61-75
Open Access | Times Cited: 8

The COVID-19 experience in Africa and the Middle East
Abdul Rahman Bizri, Nadine Al Akoury, Thulani Mhlanga, et al.
Annals of Medicine (2023) Vol. 55, Iss. 1
Open Access | Times Cited: 4

SARS-CoV-2 humoral immunity in people living with HIV-1
Boitumelo M. Motsoeneng, Jinal N. Bhiman, Simone I. Richardson, et al.
Trends in Immunology (2024) Vol. 45, Iss. 7, pp. 511-522
Open Access | Times Cited: 1

A Strategy to Detect Emerging Non-Delta SARS-CoV-2 Variants with a Monoclonal Antibody Specific for the N501 Spike Residue
Rama Devudu Puligedda, Fetweh H. Al‐Saleem, Cristoph Wirblich, et al.
Diagnostics (2021) Vol. 11, Iss. 11, pp. 2092-2092
Open Access | Times Cited: 9

SARS-CoV-2 BA.4 infection triggers more cross-reactive neutralizing antibodies than BA.1
Simone I. Richardson, Thopisang Motlou, Mieke A. van der Mescht, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 6

Page 1 - Next Page

Scroll to top